Detalhe da pesquisa
1.
Dual CTLA-4 and PD-1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first-in-human, dose-escalation, and dose-expansion study.
Cancer
; 2024 Feb 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38404184
2.
Carfilzomib, thalidomide, and dexamethasone is safe and effective in relapsed and/or refractory multiple myeloma: final report of the single arm, multicenter phase II ALLG MM018/AMN002 study.
Haematologica
; 2024 Jan 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38235519
3.
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial.
Lancet
; 391(10121): 659-667, 2018 02 17.
Artigo
Inglês
| MEDLINE | ID: mdl-29241979
4.
Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia.
Haematologica
; 104(4): 700-709, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30545923
5.
Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors.
Haematologica
; 109(1): 343-350, 2024 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37470152
6.
Oncology service initiatives and research in regional Australia.
Aust J Rural Health
; 23(1): 40-8, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25689382
7.
SARS-CoV-2 Seroprevalence in a Cohort of International Travellers Returning to Rural Australia: Enablers and Barriers to Containment of COVID-19.
Aust N Z J Public Health
; 47(1): 100003, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36680916
8.
Risk-Directed Ambulatory Thromboprophylaxis in Lung and Gastrointestinal Cancers: The TARGET-TP Randomized Clinical Trial.
JAMA Oncol
; 9(11): 1536-1545, 2023 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37733336
9.
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer.
J Clin Oncol
; 41(6): 1162-1171, 2023 02 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36791474
10.
Zanubrutinib (BGB-3111) plus obinutuzumab in patients with chronic lymphocytic leukemia and follicular lymphoma.
Blood Adv
; 4(19): 4802-4811, 2020 10 13.
Artigo
Inglês
| MEDLINE | ID: mdl-33022066
11.
Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial.
J Clin Oncol
; 34(30): 3609-3617, 2016 10 20.
Artigo
Inglês
| MEDLINE | ID: mdl-27325857
12.
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].
J Clin Oncol
; 21(12): 2237-46, 2003 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-12748244
13.
Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma.
Leukemia
; 33(11): 2762-2766, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31558766
14.
Intraluminal Superior Vena Cava Metastasis in a Patient With Poorly Differentiated Thyroid Carcinoma.
J Clin Oncol
; 33(32): e119-21, 2015 Nov 10.
Artigo
Inglês
| MEDLINE | ID: mdl-24752048
15.
Patients' and health care professionals' evaluation of health-related quality of life issues in bone metastases.
Eur J Cancer
; 45(14): 2510-8, 2009 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-19635661
16.
Guidelines for CPD accreditation of the South African Society of Medical Oncology.
S Afr Med J
; 93(10): 728, 2003 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-14652952